U.S. Markets
GE Healthcare Technologies (GEHC) Q2 2026 (USD): Revenue 5.3bln (exp. 5.26bln), adj. EPS 1.13 (exp. 1.04); sees FY adj. EPS 4.8-5.0 (exp. 4.88)
StockNow breaking-news AI analysis
GEHC reported a Q2 earnings beat and reconfirmed FY26 guidance. Despite a CFO departure, organic growth accelerated and key segments showed resilience against macro and regional headwinds.
News detail
adj. EBIT 750mln (exp. 734.6mln) Sees FY FCF at USD 1.6bln
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
